Green Thumb Industries (GTBIF) Net Margin (2019 - 2026)

Green Thumb Industries (GTBIF) posted Net Margin of 5.01% for Q1 2026, down 92.79% on a QoQ basis from 69.51% in Q4 2025, and up 201.0% year-over-year from 1.67% in Q1 2025.

Green Thumb Industries (GTBIF) Net Margin (2019 - 2026) Analysis & Trends

Green Thumb Industries' Net Margin history runs 8 years deep, the most recent figure standing at 5.01% for Q1 2026.

  • Quarterly Net Margin rose 201.0% year-over-year to 5.01% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 21.39% (up 768.0% YoY) and the FY2025 annual result came in at 21.2%, up 543.0% from the prior year.
  • Net Margin was 5.01% for Q1 2026 at Green Thumb Industries, down from 69.51% in the prior quarter.
  • Across five years, Net Margin topped out at 69.51% in Q4 2025 and bottomed at 38.18% in Q4 2022.
  • A 5-year average of 10.65% and a median of 5.42% in 2023 frame the typical range for Net Margin.
  • Annual changes were most pronounced in 2022 — Net Margin tumbled 9919 bps — and 2023, when it jumped 7031 bps.
  • Green Thumb Industries' Net Margin stood at 38.18% in 2022, then soared by 184 bps to 32.12% in 2023, then grew by 25 bps to 40.22% in 2024, then jumped by 73 bps to 69.51% in 2025, then sank by 93 bps to 5.01% in 2026.
  • Business Quant data shows GTBIF's Net Margin at 5.01% in Q1 2026, 69.51% in Q4 2025, and 8.17% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 9.29%
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 26.57%
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -33.66%
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 35.18%
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 5.03%
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 24.30%
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 4.16%
10 Green Thumb Industries 1.63 Bn 1.29 Bn 143.65 Mn 5.01%

Historic Data

Download Data
DateValue
Mar 31, 2026 5.01%
Dec 31, 2025 69.51%
Sep 30, 2025 8.17%
Jun 30, 2025 0.25%
Mar 31, 2025 3.01%
Dec 31, 2024 40.22%
Sep 30, 2024 3.06%
Jun 30, 2024 7.47%
Mar 31, 2024 11.37%
Dec 31, 2023 32.12%
Sep 30, 2023 3.92%
Jun 30, 2023 5.42%
Mar 31, 2023 3.78%
Dec 31, 2022 -38.18%
Sep 30, 2022 3.89%
Jun 30, 2022 9.72%
Mar 31, 2022 12.24%
Dec 31, 2021 61.01%
Sep 30, 2021 9.24%
Jun 30, 2021 10.49%